Skip to main content
Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Correction: Impact of bictegravir/emtricitabine/tenofovir alafenamide on health-related quality of life and economic outcomes in HIV care: Substudy of the BIC-NOW clinical trial

  • Sergio Sequera-Arquelladas,
  • María J. Vivancos,
  • David Vinuesa,
  • Antonio Collado,
  • Ignacio De Los Santos,
  • Patricia Sorni,
  • Noemi Cabello-Clotet,
  • Marta Montero,
  • Carlos Ramos Font,
  • Alberto Terron,
  • Maria José Galindo,
  • Onofre Martinez,
  • Pablo Ryan,
  • Mohamed Omar-Mohamed,
  • Helena Albendín-Iglesias,
  • Rosario Javier,
  • Alberto Romero,
  • Coral García Vallecillos,
  • Miguel Ángel Calleja,
  •  [ ... ],
  • Carmen Hidalgo-Tenorio
  • [ view all ]
  • [ view less ]

Notice of Republication

This article was republished on on January 8, 2026 to remove confidential information. Please download this article again to view the correct version.

Reference

  1. 1. Sequera-Arquelladas S, Vivancos MJ, Vinuesa D, Collado A, Santos IDL, Sorni P, et al. Impact of bictegravir/emtricitabine/tenofovir alafenamide on health-related quality of life and economic outcomes in HIV care: Substudy of the BIC-NOW clinical trial. PLoS One. 2025;20(9):e0323167. pmid:40982450